Infection Control (Disinfection & Sterilization) Global Market-Forecast to 2022

Publishing Date : September, 2016
Report Code : HCMD0137
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare system. Increase in occurrence of hospital acquired infections and advancements in sterilization and disinfection technologies are making the infection prevention and control market promising. For reduction of hospital acquired infections, infection prevention control organizations are applying epidemiologic and scientific principles and statistic analysis. Along with this, from the past decade there is a progressive refinement in sterilizing technologies from manually operated equipment to modern microprocessor controlled automatic machines. Plasma sterilization and use of electrostatics for surface disinfection are emerging and promising technologies in sterilizers and disinfectant market. Infection control products are used in a wide variety of applications like in healthcare settings, food and beverage industries, drug discovery, dental clinics and cosmetics. In recent times there is an advancement in sterilizing surgical tools in hospital settings by using robotic surgical tool sterilization process and thus promoting sufficient process of sterilization.

The global infection control market is expected to grow at a single digit high CAGR% to reach $22,582 million by 2022. Infection control market is mainly classified into products and end-users.

The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).

The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation.  However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.

The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary. 

Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.

The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market.  However stringent regulations and economic downturn and saturation are hampering the growth of the market.

The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).

 

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN AGING POPULATION
        • 3.3.1.2     INCREASE IN NUMBER OF SURGERIES PERFORMED
        • 3.3.1.3     RISING OCCURRENCE OF HOSPITAL ACQUIRED INFECTIONS
        • 3.3.1.4     INCREASING AWARENESS AMONG PEOPLE
        • 3.3.1.5     PROPER MAINTENANCE OF HYGIENE AMONG HOSPITAL STAFF
        • 3.3.1.6     RISE IN TREND FOR E-BEAM RADIATION STERILIZATION THROUGH SERVICE STERILIZATION INDUSTRY
        • 3.3.1.7     SINGLE USE TECHNOLOGY (MEDICAL NON-WOVEN) PRODUCTS, AN OPPORTUNITY ESPECIALLY IN DEVELOPING COUNTRIES
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     ECONOMIC DOWNTURN AND SATURATION OF MARKET IN DEVELOPED COUNTRIES
        • 3.3.2.2     HIGH COST OF ROBOTIC TECHNOLOGIES
        • 3.3.2.3     STRINGENT REGULATIONS
        • 3.3.2.4     AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
      • 3.3.3     CHALLENGES
        • 3.3.3.1     STERILIZATION AND DISINFECTION OF ADVANCED MEDICAL INSTRUMENTS
    • 3.4     PORTER’S FIVE FORCE ANALYSIS
      • 3.4.1     THREAT OF NEW ENTRANTS
      • 3.4.2     THREAT OF SUBSTITTES
      • 3.4.3     BARGAINING POWER OF SUPPLIERS
      • 3.4.4     BARGAINING POWER OF BUYERS
      • 3.4.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.5     REGULATORY GUIDELINES
      • 3.5.1     UNITED STATES
      • 3.5.2     EUROPE
      • 3.5.3     CHINA
      • 3.5.4     AUSTRALIA
    • 3.6     PATENT TRENDS
    • 3.7     INFECTIONS
      • 3.7.1     MICROBIAL INFECTIONS
        • 3.7.1.1     BACTERIAL INFECTIONS
          • 3.7.1.1.1     MYCOBACTERIUM TUBERCULOSIS
          • 3.7.1.1.2     CLOSTRIDIUM DIFFICILE
          • 3.7.1.1.3     ESCHERICHIA COLI
          • 3.7.1.1.4     HELICOBACTER PYLORI
          • 3.7.1.1.5     SALMONELLA
          • 3.7.1.1.6     OTHERS
        • 3.7.1.2     VIRAL INFECTIONS
          • 3.7.1.2.1     EBOLA
          • 3.7.1.2.2     HUMAN IMMUNODEFICIENCY VIRUS (HIV)
          • 3.7.1.2.3     HERPES SIMPLEX VIRUS
          • 3.7.1.2.4     YELLOW FEVER
          • 3.7.1.2.5     DENGUE FEVER
          • 3.7.1.2.6     OTHERS
        • 3.7.1.3     FUNGAL INFECTIONS
          • 3.7.1.3.1     CRYPTOCOCCUS GATTI
          • 3.7.1.3.2     ASPERGILLUS
          • 3.7.1.3.3     PNEUMOCYSTIS JIROVECI
          • 3.7.1.3.4     FUNGAL KERATITIS
          • 3.7.1.3.5     DERMATOPHYTOSIS
          • 3.7.1.3.6     OTHERS
      • 3.7.2     HEALTHCARE ASSOCIATED INFCETIONS (HCAI)
        • 3.7.2.1     HOSPITAL ACQUIRED INFECTIONS (HAI)
          • 3.7.2.1.1     CENTRAL-LINE ASSOCIATED BLOODSTREAM INFECTION (CLABSI)
          • 3.7.2.1.2     CATHETER ASSOCIATED URINARY TRACT INFECTION (CAUTI)
          • 3.7.2.1.3     SURGICAL SITE INFECTION (SSI)
          • 3.7.2.1.4     VENTILATOR-ASSOCIATED PNEUMONIA INFECTION (VAPI)
        • 3.7.2.2     COMMUNITY ACQUIRED INFECTION
          • 3.7.2.2.1     METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTION
          • 3.7.2.2.2     COMMUNITY ACQUIRED PNEUMONIA
    • 3.8     OTHER STERILIZATION AND DISINFECTION TECHNIQUES
      • 3.8.1     SUPERCRITICAL CARBON-DIOXIDE TECHNOLOGY (SF-CO2)
      • 3.8.2     NITROGEN DIOXIDES (NO2)
      • 3.8.3     PULSED ELECTRICAL FIELD (PEF) STERILIZATION
      • 3.8.4     MICROWAVE ENERGY STERILIZATION
      • 3.8.5     PHOTOCATALYSIS
      • 3.8.6     ULTRASONIC TECHNOLOGY
    • 3.9     MARKET SHARE ANALYSIS
  • 4     INFECTION CONTROL GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     DISINFECTION
      • 4.2.1     INTRODUCTION
      • 4.2.2     DISINFECTORS
        • 4.2.2.1     WASHER DISINFECTORS
        • 4.2.2.2     FLUSHERS DISINFECTORS
        • 4.2.2.3     UV RAYS DISINFECTORS
      • 4.2.3     ENDOSCOPE REPROCESSORS
      • 4.2.4     DISINFECTANTS
        • 4.2.4.1     BY PRODUCT TYPE
          • 4.2.4.1.1     HAND
          • 4.2.4.1.2     SKIN
          • 4.2.4.1.3     SURFACE
          • 4.2.4.1.4     INSTRUMENT
        • 4.2.4.2     BY ENVIRONMENTAL PROTECTION AGENCY (EPA) CLASSIFICATION
          • 4.2.4.2.1     LOW-LEVEL DISINFECTANTS (LLD)
          • 4.2.4.2.2     INTERMEDIATE-LEVEL DISINFECTANTS (ILD)
          • 4.2.4.2.3     HIGH-LEVEL DISINFECTANTS (HLD)
      • 4.2.5     PERSONAL PROTECTIVE EQUIPMENTS
        • 4.2.5.1     GLOVES AND FOOT COVERS
        • 4.2.5.2     SURGICAL MASKS AND RESPIRATORS
        • 4.2.5.3     SURGICAL DRAPES AND GOWNS
        • 4.2.5.4     DISINFECTANT WIPES
        • 4.2.5.5     OTHERS
          • 4.2.5.5.1     PROTECTIVE EYE-WEARS
          • 4.2.5.5.2     STERILIZATION WRAPS
    • 4.3     STERILIZATION
      • 4.3.1     INTRODUCTION
      • 4.3.2     STERILIZATION, BY METHOD
        • 4.3.2.1     HEAT STERILIZATION
          • 4.3.2.1.1     WET/MOIST HEAT STERILIZATION
            • 4.3.2.1.1.1     VERTICAL AUTOCLAVE
            • 4.3.2.1.1.2     HORIZONTAL AUTOCLAVE
            • 4.3.2.1.1.3     PORTABLE AUTOCLAVE
          • 4.3.2.1.2     DRY HEAT STERILIZATION
          • 4.3.2.1.3     LOW TEMPERATURE STERILIZATION
            • 4.3.2.1.3.1     ETHYLENE OXIDE STERILIZATION
            • 4.3.2.1.3.2     HYDROGEN PEROXIDE
            • 4.3.2.1.3.3     VAPOR HYDROGEN PEROXIDE STERILIZATION
            • 4.3.2.1.3.4     PERACETIC ACID
            • 4.3.2.1.3.5     OZONE GAS
            • 4.3.2.1.3.6     FORMALDEHYDE STERILIZATION
            • 4.3.2.1.3.7     CHLORINE DIOXIDE STERILIZATION
          • 4.3.2.1.4     FILTRATION STERILIZATION
          • 4.3.2.1.5     RADIATION STERILIZATION
            • 4.3.2.1.5.1     IONIZING RADIATION
            • 4.3.2.1.5.2     NON-IONIZING RADIATION
      • 4.3.3     STERILIZATION BY SERVICES
        • 4.3.3.1     IN-HOUSE STERILIZATION SERVICES
          • 4.3.3.1.1     ETHYLENE OXIDE STERILIZATION
          • 4.3.3.1.2     E-BEAM STERILIZATION
          • 4.3.3.1.3     GAMMA STERILIZATION
          • 4.3.3.1.4     OTHER IN-HOUSE STERILIZATION SERVICES
        • 4.3.3.2     CONTRACT STERILIZATION SERVICES
          • 4.3.3.2.1     ETHYLENE OXIDE STERILIZATION
          • 4.3.3.2.2     E-BEAM STERILIZATION
          • 4.3.3.2.3     GAMMA STERILIZATION
          • 4.3.3.2.4     OTHER CONTRACT STERILIZATION SERVICES
  • 5     INFECTION CONTROL GLOBAL MARKET, BY END-USERS
    • 5.1     INTRODUCTION
    • 5.2     PHARMACEUTICALS
    • 5.3     BIOTECHNOLOGY
    • 5.4     HOSPITALS
      • 5.4.1     DENTAL CLINICS
      • 5.4.2     NURSING CENTERS
      • 5.4.3     AMBULATORY SURGICAL CENTRES
    • 5.5     RESEARCH LABORATORIES
    • 5.6     OTHERS
      • 5.6.1     COSMETICS
      • 5.6.2     FOOD AND BEVERAGE
      • 5.6.3     VETERINARY
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     UNITED STATES
      • 6.2.2     CANADA
    • 6.3     EUROPE
    • 6.4     ASIA-PACIFIC
      • 6.4.1     INDIA
      • 6.4.2     CHINA
      • 6.4.3     JAPAN
    • 6.5     REST OF THE WORLD
      • 6.5.1     SOUTH AFRICA
      • 6.5.2     MIDDLE EAST
  • 7     COMPETITIVE LANDSCAPE
    • 7.1     INTRODUCTION
    • 7.2     NEW PRODUCT LAUNCHES
    • 7.3     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
    • 7.4     APPROVALS
    • 7.5     EXPANSIONS
    • 7.6     MERGERS & ACQUISITIONS
  • 8     MAJOR COMPANIES
    • 8.1     3M COMPANY
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     ANSELL LIMITED
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     CANTEL MEDICAL
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     GETINGE GROUP
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     HALYARD HEALTH INC.
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     HARTMANN
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     JOHNSON & JOHNSON (ADVANCED STERILIZATION PRODUCTS)
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     METALL ZUG (BELIMED)
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     STERIGENICS INTERNATIONAL, INC.
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     STERIS CORPORATION
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 2     INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 3     INFECTION CONTROL GLOBAL MARKET REVENUE, BY ENDUSERS, (2014-2022) ($MN)
      • TABLE 4     INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 5     INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 6     INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 7     INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 8     INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 9     INFECTION CONTROL WASHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 10     INFECTION CONTROL FLUSHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 11     INFECTION CONTROL UV RAYS DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 12     INFECTION CONTROL ENDOSCOPE REPROCESSORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 13     INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 15     INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 16     INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 17     INFECTION CONTROL HAND DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 18     INFECTION CONTROL SKIN DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 19     INFECTION CONTROL SURFACE DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 20     INFECTION CONTROL INSTRUMENT DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 21     INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 22     INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 23     INFECTION CONTROL LOW-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 24     INFECTION CONTROL INTERMEDIATE-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 25     INFECTION CONTROL HIGH-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 26     INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 27     INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 28     INFECTION CONTROL GLOVES AND FOOT COVERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 29     INFECTION CONTROL SURGICAL MASKS AND RESPIRATORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     INFECTION CONTROL SURICAL DRAPES AND GOWNS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 31     INFECTION CONTROL DISINFECTANT WIPES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 32     INFECTION CONTROL OTHER PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 33     INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 34     INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 35     INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 36     INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 37     INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 38     INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 39     INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 41     INFECTION CONTROL VERTICAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 42     INFECTION CONTROL HORIZONTAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 43     INFECTION CONTROL PORTABLE AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 44     INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 45     INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 46     INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 47     INFECTION CONTROL ETHYLENE OXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 48     INFECTION CONTROL HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATIONGLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     INFECTION CONTROL VAPOR HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 50     INFECTION CONTROL PERACETIC ACID LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 51     INFECTION CONTROL OZONE GAS LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 52     INFECTION CONTROL FORMALDEHYDE LOW TEMPERATURE STERILZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 53     INFECTION CONTROL CHLORINE DIOXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 54     INFECTION CONTROL FILTRATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 55     INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 56     INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
      • TABLE 57     INFECTION CONTROL IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 58     INFECTION CONTROL NON-IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 59     INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 60     INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 61     INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 62     INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 63     INFECTION CONTROL ETHYLENE OXIDE IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 64     INFECTION CONTROL E-BEAM IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 65     INFECTION CONTROL GAMMA IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 66     INFECTION CONTROL OTHER IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 67     INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 68     INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 69     INFECTION CONTROL ETHYLENE OXIDE CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 70     INFECTION CONTROL E-BEAM CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 71     INFECTION CONTROL GAMMA CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 72     INFECTION CONTROL OTHER CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 73     INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 74     INFECTION CONTROL PHARMACEUTICAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 75     INFECTION CONTROL BIOTECHNOLOGY END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 76     INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 77     INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 78     INFECTION CONTROL DENTAL CLINIC END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 79     INFECTION CONTROL NURSING CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 80     INFECTION CONTROL AMBULATORY SURGICAL CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 81     INFECTION CONTROL RESEARCH LABORATORIES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 82     INFECTION CONTROL OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 83     INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 84     NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 85     NORTH AMERICAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 86     NORTH AMERICAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 87     NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 88     NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
      • TABLE 89     NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
      • TABLE 90     NORTH AMERICAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 91     NORTH AMERICAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 92     NORTH AMERICAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 93     NORTH AMERICAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 94     NORTH AMERICAN INFECTION CONTROL WET/MOIST HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 95     NORTH AMERICAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 96     NORTH AMERICAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 97     NORTH AMERICAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 98     NORTH AMERICAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 99     NORTH AMERICAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 100     NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 101     NORTH AMERICAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 102     EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 103     EUROPEAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 104     EUROPEAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 105     EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 106     EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
      • TABLE 107     EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
      • TABLE 108     EUROPEAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 109     EUROPEAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 110     EUROPEAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 111     EUROPEAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 112     EUROPEAN INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 113     EUROPEAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 114     EUROPEAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 115     EUROPEAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 116     EUROPEAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 117     EUROPEAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 118     EUROPEAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 119     EUROPEAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 120     ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 121     ASIA-PACIFIC INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 122     ASIA-PACIFIC INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 123     ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 124     ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
      • TABLE 125     ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
      • TABLE 126     ASIA-PACIFIC INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 127     ASIA-PACIFIC INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 128     ASIA-PACIFIC INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 129     ASIA-PACIFIC INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 130     ASIA-PACIFIC INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 131     ASIA-PACIFIC INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 132     ASIA-PACIFIC INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 133     ASIA-PACIFIC INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 134     ASIA-PACIFIC INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 135     ASIA-PACIFIC INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 136     ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 137     ASIA-PACIFIC INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 138     REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
      • TABLE 139     REST OF THE WORLD INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 140     REST OF THE WORLD INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 141     REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 142     REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
      • TABLE 143     REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
      • TABLE 144     REST OF THE WORLD INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 145     REST OF THE WORLD INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 146     REST OF THE WORLD INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 147     REST OF THE WORLD INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 148     REST OF THE WORLD INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 149     REST OF THE WORLD INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 150     REST OF THE WORLD INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 151     REST OF THE WORLD INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 152     REST OF THE WORLD INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 153     REST OF THE WORLD INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 154     REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 155     REST OF THE WORLD INFECTION CONTROL HOSPITAL ENDUSERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 156     NEW PRODUCT LAUNCHES (2014-2016)
      • TABLE 157     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2014-2016)
      • TABLE 158     APPROVALS (2014-2016)
      • TABLE 159     EXPANSIONS (2014-2016)
      • TABLE 160     MERGERS & ACQUISITIONS (2014-2016)
      • TABLE 161     3M COMPANY : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 162     3M COMPANY : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
      • TABLE 163     3M COMPANY : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
      • TABLE 164     ANSELL LIMITED : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 165     ANSELL LIMITED : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 166     ANSELL LIMITED : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 167     CANTEL MEDICAL : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 168     CANTEL MEDICAL : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 169     CANTEL MEDICAL : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 170     GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 171     GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
      • TABLE 172     HALYARD HEALTH INC, : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 173     HALYARD HEALTH INC, : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 174     HALYARD HEALTH INC, : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 175     HARTMANN : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 176     HARTMANN : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
      • TABLE 177     HARTMANN : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
      • TABLE 178     JOHNSON & JOHNSON : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 179     JOHNSON & JOHNSON : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 180     JOHNSON & JOHNSON : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 181     METALL ZUG : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 182     METALL ZUG : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
      • TABLE 183     METALL ZUG : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
      • TABLE 184     STERIS CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 185     STERIS CORPORATION : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 186     STERIS CORPORATION : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)

      LIST OF FIGURES

      • FIGURE 1     INFECTION CONTROL GLOBAL MARKET SHARE AND REVENUE, BY REGION, (2014-2022) ($MN)
      • FIGURE 2     INFECTION CONTROL GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     INFECTION CONTROL GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     INFECTION CONTROL GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     INFECTION CONTROL GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     INFECTION CONTROL GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     INFECTION CONTROL GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     INFECTION CONTROL GLOBAL MARKET: PCT PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 10     INFECTION CONTROL GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
      • FIGURE 11     INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2015 V’S 2022) ($MN)
      • FIGURE 12     INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 13     INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 14     INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 15     DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 16     DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 17     PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
      • FIGURE 18     INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 19     INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY METHODS, (2015 V’S 2022) ($MN)
      • FIGURE 20     INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 21     LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
      • FIGURE 22     INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 23     INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY SERVICES, (2015 V’S 2022) ($MN)
      • FIGURE 24     INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 25     INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 26     INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2015 V’S 2022) ($MN)
      • FIGURE 27     HOSPITALS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 28     INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN), (CAGR %)
      • FIGURE 29     NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
      • FIGURE 30     NORTH AMERICAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 31     EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
      • FIGURE 32     EUROPEAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 33     ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
      • FIGURE 34     ASIA-PACIFIC DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 35     REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
      • FIGURE 36     REST OF THE WORLD DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 37     KEY GROWTH STRATEGIES, (2014 – 2016)
      • FIGURE 38     SWOT: 3M COMPANY
      • FIGURE 39     SWOT: ANSELL LIMITED
      • FIGURE 40     SWOT: CANTEL MEDICAL
      • FIGURE 41     SWOT: GETINGE GROUP
      • FIGURE 42     SWOT: HALYARD HEALTH INC.
      • FIGURE 43     SWOT: HARTMANN GROUP
      • FIGURE 44     SWOT: JOHNSON & JOHNSON
      • FIGURE 45     SWOT: BELIMED
      • FIGURE 46     SWOT: STERIGENICS INTERNATIONAL INC.
      • FIGURE 47     SWOT: STERIS CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3M COMPANY
      • 2     ADVANCED STERILIZATION PRODUCTS
      • 3     AHLSTROM
      • 4     AMERIWATER
      • 5     AMTEK, INC
      • 6     ANDERSEN CALEDONIA
      • 7     ANDERSON STERILIZERS, INC
      • 8     ANGELINI
      • 9     ANIOS LABORATORIES
      • 10     ANSELL LIMITED
      • 11     ARC HEALTHCARE SOLUTIONS
      • 12     ARJOHUNHEIGH
      • 13     AT-OS
      • 14     B. BRAUN MELSUNGEN AG
      • 15     B. BRAUN SINGAPORE PTE. LTD
      • 16     BAUMER GROUP
      • 17     BEAM ONE LLC
      • 18     BECTON, DICKSON AND COMPANY
      • 19     BEIJING MEDOS AT BIOTECHNOLOGY CO LTD
      • 20     BELIMED
      • 21     BELINTRA
      • 22     BIOQUELL INC
      • 23     BLACK DIAMOND VIDEO, INC
      • 24     C.S. MEDICAL
      • 25     CANNON WATER TECHNOLOGY, INC
      • 26     CANON LIFECARE SOLUTION INC
      • 27     CANTEL MEDICAL
      • 28     CARE FUSION
      • 29     CHEMIE GMBH
      • 30     CIENTURION
      • 31     CLORDISYS SOLUTIONS INC
      • 32     CLOROX HEALTHCARE
      • 33     COLOPLAST
      • 34     COMPANHIA BRASILEIRA DE ESTERILIZAÇÃO
      • 35     CONSOLIDATED STERILIZER SYSTEMS
      • 36     CPAC EQUIPMENT INC
      • 37     CROSSTEX INTERNATIONAL
      • 38     DEGREMONT TECHNOLOGIES
      • 39     DISCHER TECHNIK GMBH
      • 40     DIVERSEY INC
      • 41     DRAVON MEDICAL INC
      • 42     E-BEAM SERVICES INC,
      • 43     ECOLAB INCORPORATED
      • 44     E-MIST INNOVATIONS INC
      • 45     ENDUROCIDE
      • 46     ETHOX CORPORATION
      • 47     EUROPLAZ TECHNOLOGIES
      • 48     EVONIK INDUSTRIES
      • 49     EVOQUA WATER TECHNOLOGIES
      • 50     GAMMARAD
      • 51     GE HEALTHCARE
      • 52     GENE THERAPY SYSTEMS, INC
      • 53     GENERAL ECONOPAK INC
      • 54     GETINGE GROUP
      • 55     GOJO INDUSTRIES
      • 56     HA2 MEDIZINTECHNIK GMBH
      • 57     HALYARD HEALTH
      • 58     HARTMANN GROUP
      • 59     HOYA CORPORATION
      • 60     HU-FRIEDLY B.V.
      • 61     INNOVATEK MEDICAL INC
      • 62     INTEGRATED MEDICAL SYSTEMS INTERNATIONAL, INC
      • 63     INTERNATIONAL MEDICAL SERVICE
      • 64     INVENDO MEDICAL GMBH
      • 65     INVENIO HEALTHCARE
      • 66     KEN A/S
      • 67     L-3 APPLIED TECHNOLOGIES
      • 68     LIFE SCIENCE OUTSOURCING, INC
      • 69     MAXILL
      • 70     MEDICAL INNOVATIONS
      • 71     MEDIPLAST LIMITED
      • 72     MEDISAFE INTERNATIONAL
      • 73     MEDIVATORS
      • 74     MEDLINE
      • 75     METREX RESEARCH
      • 76     MICRO SCIENTIFIC INDUSTRIES
      • 77     MICROGARD
      • 78     MIELE PROFESSIONAL
      • 79     MOLNLYCKE HEALTHCARE
      • 80     MRLB INTERNATIONAL INC
      • 81     MUTIGATE
      • 82     NANOSONICS LIMITED
      • 83     NELSON LABORATORIES, INC.
      • 84     NORDION, INC
      • 85     NOVIRA THERAPEUTICS INC
      • 86     NOXILIZER, INC
      • 87     NUTEK CORPORATION
      • 88     OLYMPUS AMERICA
      • 89     PACIFIC INTEGRATED MANUFACTURING, INC
      • 90     PALMERO HEALTHCARE
      • 91     PALVUS
      • 92     PANASONIC BIOMEDICAL
      • 93     PARTNERTECH
      • 94     PDI HEALTHCARE
      • 95     PEROXYCHEM HOLDINGS
      • 96     PRECEPT MEDICAL PRODUCTS, INC
      • 97     PRISTINE MEDICALS
      • 98     PRO-TECH
      • 99     PURE WATER SOLUTIONS, INC.
      • 100     PURELINE
      • 101     PURICORE INTERNATIONAL LIMITED
      • 102     RENU MEDICALS
      • 103     REVOX STERILIZATION SOLUTIONS
      • 104     SCHOTTLANDER & DAVIS LTD
      • 105     SCHULKE & MAYR
      • 106     SCICAN
      • 107     SEMPERIT AG HOLDING
      • 108     SLYTRON’S
      • 109     SORVAN RADIATION LTD
      • 110     STEELCO
      • 111     STERICOOL
      • 112     STERIGENICS INTERNATIONAL INC
      • 113     STERILOX TECHNOLOGIES INC
      • 114     STERILUCENT, INC
      • 115     STERIS CORPORATION
      • 116     STERI-TEK
      • 117     STIEGELMEYER
      • 118     SYNERGY HEALTH
      • 119     SYNTHES INC
      • 120     TELSTAR
      • 121     TERRAGENE
      • 122     THEA-TEX HEALTHCARE PVT LTD
      • 123     THERMO FISHER SCIENTIFIC
      • 124     TOTALCARE
      • 125     TRISTEL
      • 126     TROJANUV
      • 127     TSO3
      • 128     TUTTNAUER
      • 129     UNITED INDUSTRIES GROUP, INC
      • 130     WASHINGTON TRADE INTERNATIONAL INC
      • 131     WASSENBURG MEDICAL B.V.
      • 132     WHITELEY MEDICAL
      • 133     XENEX DISINFECTION SERVICES
      • 134     XO1 LIMITED